Cato Research Ltd. (Cato Research) is a healthcare services company that offers research and development services to its customers in the pharmaceutical and biotechnology industry. The company offers services to its customers to develop new biologics, drugs and medical devices. The services offered by the company include design and execution of regulatory strategy, management and monitoring of preclinical and toxicology studies, management of data processing, design and implementation of preclinical development programs. In addition, it also offers various services like preparation, compilation and submission of grants and management and conduct of due diligence activities for emerging technologies. The company operates in Israel, Germany, Austria, Latvia, South Africa and the US. It operates as a subsidiary of Cato Holding Company. Recently, the company has agreement with Merge Healthcare to provide an additional technology for clinical trials management. Cato Research is headquartered at Durham in North Carolina, the US.

Street: 
Westpark Corporate Cente
City: 
Durham
Postcode: 
27713-2220
Federal State : 
United States
WebSite: 
www.cato.com
Fax: 
1-919-3612290

Company Index Score

Current Index Score Historical Index Score
  • Cato Research Ltd. currently scores 50 % in the index.
  • Cato Research Ltd. is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Cato Research Ltd. is currently ranked 1 out of 4535 companies. This is in the top 0.022 % percent of Pharmaceutical companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets